Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for JNJ
Company Monitoring Page for JNJ
latest headlines for company on cafepharma
Cancer victims lose bid to block proposed J&J talc bankruptcy
Reuters
Sun, 06/30/24 - 09:49 pm
Tags:
JNJ
,
legal
,
bankruptcy
,
cancer
Despite J&J's Rybrevant full nod, FDA encourages Dizal to file rival lung cancer drug for accelerated approval
Fierce Pharma
Thu, 06/27/24 - 10:08 pm
Tags:
JNJ
,
Rybrevant
,
Dizal Pharma
,
FDA
,
non-small cell lung cancer
How Pfizer, Bristol Myers Squibb and Johnson & Johnson Are Confronting Patent Cliffs
BioSpace
Wed, 06/26/24 - 09:54 am
Tags:
patents
,
Pfizer
,
Bristol Myers Squibb
,
JNJ
,
patent cliffs
J&J’s Blockbuster Tremfya Flops in Phase II Giant Cell Arteritis Trial
BioSpace
Tue, 06/25/24 - 11:33 am
Tags:
JNJ
,
Tremfya
,
clinical trials
,
giant cell arteritis
Supreme Court gives pharma giants another chance to sidestep terrorism-funding case
Fierce Pharma
Mon, 06/24/24 - 10:08 pm
Tags:
legal
,
AstraZeneca
,
GE Healthcare
,
JNJ
,
Pfizer
,
Roche
,
terrorism
J&J MedTech Launch Polyphonic Digital Surgical Ecosystem
Medtech Dive
Thu, 06/20/24 - 05:59 pm
Tags:
Medtech
,
JNJ
,
Polyphonic
,
digital surgical ecosystem
J&J to seek appeal of $150M verdict in long-spanning HIV meds off-label marketing case
Fierce Pharma
Mon, 06/17/24 - 10:31 pm
Tags:
JNJ
,
Janssen
,
off-label
,
HIV
,
legal
,
whistleblower lawsuits
,
Prezista
,
Intelence
J&J commits five-year investment in Italian medicine manufacturing
European Pharmaceutical Review
Mon, 06/17/24 - 10:29 pm
Tags:
JNJ
,
Johnson & Johnson Innovative Medicine
,
Italy
,
drug manufacturing
J&J’s $6.5B Momenta Buy Pays Off With Phase II Sjögren’s Disease Win
BioSpace
Mon, 06/17/24 - 11:36 am
Tags:
JNJ
,
clinical trials
,
nipocalimab
,
Sjögren’s syndrome
,
Momenta
Johnson & Johnson reaches $700 million talc settlement with US states
Reuters
Wed, 06/12/24 - 11:50 am
Tags:
JNJ
,
legal
,
settlements
J&J-backed Bright Peak secures $90m to advance immunoconjugate program
Pharmaceutical Technology
Tue, 06/11/24 - 11:29 am
Tags:
Bright Peak Therapeutics
,
funding
,
JNJ
,
immunoconjugates
Colorado drug review board finds J&J's Stelara unaffordable, teeing up potential statewide price cap
Fierce Pharma
Tue, 06/11/24 - 11:20 am
Tags:
Colorado
,
JNJ
,
Stelara
,
drug pricing
J&J's CMO William Hait slated to depart this fall
Fierce Biotech
Tue, 06/11/24 - 11:11 am
Tags:
JNJ
,
CMOs
Vanda, after rejecting Future Pak offer, gets $466M takeout bid from Cycle Pharma
Fierce Pharma
Thu, 06/6/24 - 11:29 am
Tags:
Vanda Pharmaceuticals
,
JNJ
,
M&A
,
Cycle Pharma
,
Future Pak
,
Fanapt
Oregon jury says Johnson & Johnson must pay $260M in mesothelioma talc case
Fierce Pharma
Tue, 06/4/24 - 11:27 pm
Tags:
JNJ
,
legal
,
ovarian cancer
,
mesothelioma
,
Oregon
ASCO 24: Data shows survival benefit with J&J’s subcutaneous Rybrevant
Clinical Trials Arena
Mon, 06/3/24 - 12:03 pm
Tags:
ASCO 2024
,
JNJ
,
Rybrevant
,
non-small cell lung cancer
ASCO24 preview: A look at some of the cancer meeting’s hottest abstracts
BioSpace
Fri, 05/31/24 - 11:03 am
Tags:
ASCO 2024
,
Merus
,
JNJ
,
CAR-T
,
Legend Biotech
,
Pfizer
,
Genmab
,
Nanobiotix
Smaller Biopharma M&A on Upswing, Deals Expected to Continue Through 2024
BioSpace
Fri, 05/31/24 - 10:59 am
Tags:
M&A
,
Merck
,
EyeBio
,
JNJ
,
Numab Therapeutics
,
Asahi Kasei
,
Calliditas Therapeutics
J&J's depression treatment succeeds in late-stage study
Yahoo/Reuters
Wed, 05/29/24 - 11:45 am
Tags:
JNJ
,
major depressive disorder
,
clinical trials
,
seltorexant
J&J scoops up another atopic dermatitis antibody in $1.25B Numab rights deal
Fierce Biotech
Tue, 05/28/24 - 11:02 am
Tags:
JNJ
,
atopic dermatitis
,
bispecific antibodies
,
Numab Therapeutics
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.